By G HossainPosted on August 6, 2025Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs From tariffs to drug pricing to the FDA, biopharma CEOs find themselves pulled into policy discussions on this year’s second quarter earnings calls. Biopharma CEOs Can’t Dodge Policy Questions as Trump Lobs Wrench into Earnings Season Post navigation FDA In Flux, Pfizer Talks to Trump on MFN, Merck Cuts 6K Jobs, MoreBioNTech Cuts 90 Jobs Amid ‘Strategic Alignment’